The Charles River assay development and screening department offers a unique combination of target class and cell biology expertise together with state-of-the-art instrumentation to provide services tailored to your requirements.

We provide a collaborative environment and work closely with our teams in medicinal chemistry, ADME, structural biology and fragment-based drug discovery to deliver within challenging timelines.

Upcoming Webinar

Planning Ahead for CiPA Stem Cell Assays
December 9, 2014
1:00 - 2:00 PM EST


I need to...